baber/WOPTO huggingface dataset:
Patent BR-122017018553-B1 (BR)
Title: Método e aparelho para a determinação de um fator de escala otimizado
Inventor: KANIEWSKA MAGDALENA
IPC: G10L21/038
Filed: 2014-07-04
Abstract: A presente invenção refere-se a um processo de determinação de um fator de escala otimizado para aplicar em um sinal de excitação ou em um filtro no momento de um processo de extensão de banda de frequência de um sinal de audiofrequência, o processo de extensão de banda (E601) compreendendo uma etapa de decodificação ou de extração, em uma primeira banda de frequência, de um sinal de excitação e de parâmetros da primeira banda de frequência compreendendo coeficientes de um filtro de predição linear, uma etapa de geração de um sinal de excitação estendido pelo menos sobre uma segunda banda de frequência e uma etapa de filtragem por um filtro de predição linear para a segunda banda de frequência. O processo de determinação compreende as etapas de determinação (E602) de um filtro de predição linear chamado filtro adicional, de ordem inferior ao filtro de predição linear da primeira banda de frequência, os coeficientes do filtro adicional sendo obtidos a partir dos parâmetros decodificados ou extraídos da primeira banda de frequência e de cálculo (E603) do fator de escala otimizado em função pelo menos dos coeficientes do filtro adicional. A invenção se refere também a um dispositivo de determinação de (...).
Patent BR-122017022817-B1 (BR)
Title: Composição e método para controlar doença de planta compreendendo um composto de carboxamida e um composto de azol
Inventor: Yuichi matsuzaki
IPC: A01N47/38
Filed: 2011-04-25
Abstract: a presente invenção refere-se a uma composição compreendendo um composto de carboxamida representado pela seguinte fórmula (i), em que r1 representa um átomo de hidrogênio ou um grupo metila, e r2 representa um grupo metila, um grupo difluorometila ou um grupo trifluorometila, e um ou mais compostos de azol selecionados a partir do grupo (a) consistindo em propiconazol, protioconazol, triadimenol, procloraz, penconazol, tebuconazol, flusilazol, diniconazol, bromuconazol, epoxiconazol, difenoconazol, ciproconazol, metc.onazol, triflumizol, tetraconazol, miclobutanil, fenbuconazol, hexaconazol, fluquinconazol, triticonazol, bitertanol, imazalil, ipconazol, simeconazol, himexazol, etridiazol e flutriafol.
Patent BR-122020009091-B1 (BR)
Title: Método para purificar reb x
Inventor: AVETIK MARKOSYAN
IPC: A23L27/00
Filed: 2012-12-19
Abstract: trata-se de métodos para purificar glicosídeos de esteviol, que incluem rebaudiosídeo x. o adoçante e o elemento adoçado que contêm rebaudiosídeo x também são fornecidos no presente documento. os métodos para aprimorar o sabor e aroma e/ou o perfil temporal de composições adoçáveis, como bebidas, também são fornecidos.
Patent CS-198120-B2 (CS)
Title: Device for concentrating the solution of the substance in the solvent
Inventor: HUSKEN ALBERT
IPC: B01D1/16
Filed: 1973-06-21
Abstract: 1411862 Concentrating phosphoric acid by evaporation PROREA 22 June 1973 [22 June 1972] 29910/73 Heading C1A [Also in Division B1] Aqueous phosphoric acid having a concentration equivalent to a P 2 O 5  content of 25-35% by weight is concentrated to 50-60% by weight by evaporation by introducing the solution at 17 at 2080 kg./hr. to tank 1 so that it passes in countercurrent to hot air at 500‹ C. introduced from duct 4 at 20,000 m<SP>3</SP>./hr., the air passing over the top of the solution. Stirrers 10 disperse drops of liquid in the gas, and device 21 measures the acid concentration and adjusts gas heater and flow controller 20 if necessary to achieve the desired concentration.
Patent CS-217971-B2 (CS)
Title: Method of processing acidic petroleum distillates with contents of the mercaptane
Inventor: FRAME ROBERT
IPC: C01G27/06
Filed: 1979-08-24
Abstract: A process for treating a mercaptan-containing sour petroleum distillate is disclosed. A sour petroleum distillate, in admixture with an oxidizing agent, is passed into contact with a catalytic composite in the presence of an alkaline reagent, said catalytic composite comprising a metal chelate mercaptan oxidation catalyst and a quaternary ammonium compound impregnated on a solid adsorbent support disposed as a fixed bed in a first treating zone. The effluent from said first zone, in admixture with an oxidizing agent, is then passed into contact with a catalytic composite in the presence of an alkaline reagent, said catalytic composite comprising a metal chelate mercaptan oxidation catalyst impregnated on a solid adsorbent support disposed as a fixed bed in a second treating zone. A petroleum distillate, substantially free of mercaptan sulfur, is recovered from the second treating zone.
Patent CS-247074-B2 (CS)
Title: Electromagnetic fixture clamp
Inventor: GASPER REINHOLD
IPC: B23Q3/15
Filed: 1983-08-31
Abstract: PCT No. PCT/AT83/00026 Sec. 371 Date May 2, 1984 Sec. 102(e) Date May 2, 1984 PCT Filed Aug. 26, 1983 PCT Pub. No. WO84/00914 PCT Pub. Date Mar. 15, 1984.In an electromagnetic beam respectively a beam- or carrier-like worktable for pressure coating and other processing machines operating with magnetic contact pressure, at least one pole end of the magnet cores of the electromagnet is connected in a heatproof manner by means of a magnet-connecting bridge with a support profile symmetric to the plane of the magnet core axes.
Patent JP-H0321063-B2 (JP)
IPC: G01N27/07
Filed: 1983-01-11
Abstract: An apparatus and method for measuring the concentration of various components in a fluid sample. The apparatus comprises a chemically sensitive field effect transistor (CHEMFET) having a semiconductor substrate and a pair of diffusion regions formed at the surface of the substrate. An electrical insulating layer is positioned adjacent the substrate and a fluid pervious bridge member is mounted to the insulating layer so as to form a gap between the bridge member and insulating layer. The apparatus also includes means for imposing an electrical charge on the bridge member, means for imposing an electrical potential between the diffusion regions, and means for detecting current flow between the diffusion regions. The fluid sample to be analyzed is introduced through the fluid pervious bridge member and into the gap where various components of the fluid sample are adsorbed by the bridge member, and in another embodiment, also by an adsorptive layer which is applied within the gap. The adsorptive layer can be specifically chosen so as to render the apparatus chemically selective of one or more fluid components.
Patent AU-549272-B2 (AU)
Title: Insulin b30 amino acid interchange using carboxypeptidase
Inventor: BREDDAM KLAUS
IPC: C12P21/02
Filed: 1983-01-19
Granted: 1986-01-23
Abstract: The B-30 amino acid in insulins is replaced enzymatically by
 reacting as substrate component the selected insulin Ins-X, wherein X represents the B-30 amino acid
 with an amine component selected from the group consisting of
 (a) L-amino acids of the formula
 H - B - OH
 wherein B is an L-amino acid residue,
 (b) optionally N-substituted L-amino acid amides of the formula
 H - B - NR<1>R<2>
 wherein B is an L-amino acid residue and R<1> and R<2> are independently selected from the group consisting of hydrogen, amino, hydroxy, alkyl, cycloalkyl, aryl, heteroaryl and aralkyl or R<1> and R<2> together with the nitrogen atom form a heterocyclic group which may contain a furter hetero atom, and
 (c) amino acid esters of the formula
 H - B - OR<3>
 wherein B is an L-amino acid residue and R<3> represents alkyl, cycloa)kyl, aryl, heteroaryl or aralkyl, in the presence of an L-specific serine carboxypeptidase enzyme, preferably carboxypeptidase Y, which has been chemically modified at the sulfhydryl group by reaction with divalent metal ions, in an aqueous solution or dispersion containing halogen or pseudohalogen ions and having a pH from about 5 to 10.5, thereby to form an insulin derivative
 Ins-B-OH, Ins-B-NR<1>R<2>,
 Ins-B-B-NR<1>R<2> or Ins-B-OR<3>
 and subsequently cleaving a group -NR<1>R<2>, - B-NR<1>R<2>, or -OR<3>, if desired, by using a modified or unmodified serine carboxypeptidase enzyme. 
<??>By using porcine insulin as substrate component and threonine as the amino acid forming part of the amine component human insulin is obtained.
Patent AU-690945-B2 (AU)
Title: Thermoplastic resin foam and method of production thereof
Inventor: KOBAYASHI TOMOYUKI
IPC: B32B5/18
Filed: 1994-12-14
Granted: 1998-05-07
Abstract: An object of the present invention is to provide a foam molding which is light, excellent in bending strength, and excellent in balance between compressive strength and compression permanent strain, being a foam in which thermoplastic resin high expanded foams whose overall outer surfaces are covered with thermoplastic resin low-expanded-foam thin layers are thermally fused with each other through the aforementioned low-expanded-foam thin layers. <IMAGE>
Patent AU-698144-B2 (AU)
Title: Process of sugarless hard coating and products obtained therefrom
Inventor: SERPELLONI MICHEL
IPC: A23L1/09
Filed: 1997-01-31
Granted: 1998-10-22
Abstract: The subject of the present invention is an improved hard-coating process using a polyol in the powdered state and permitting the easy and rapid creation of a hard coating at the surface of a product. This process consists, on the one hand, in applying a syrup containing at least 90% of a polyol chosen from sorbitol, maltitol, mannitol, xylitol, erythritol, lactitol and isomalt and, on the other hand, in the application in powdered form, of a quantity of powder having a purity greater than 95% with respect to the same polyol, these applications being performed without carrying out a forced drying.
Patent AU-698744-B2 (AU)
Title: Oil-in-water emulsions
Inventor: FRISCH GERHARD
IPC: A01N25/04
Filed: 1994-12-14
Granted: 1998-11-05
Abstract: PCT No. PCT/EP94/04141 Sec. 371 Date Aug. 29, 1996 Sec. 102(e) Date Aug. 29, 1996 PCT Filed Dec. 14, 1994 PCT Pub. No. WO95/17087 PCT Pub. Date Jun. 29, 1995The present invention relates to oil-in-water emulsions containing 0.001-70% by weight of at least one active substance from the group consisting of phosphates, thiophosphates and/or carbamates, 0.001-30% by weight of one or more surfactant compounds from the group consisting of nonionic surfactant compounds or phosphorylated surfactant compounds or sulfated surfactant compounds or sulfonated surfactant compounds, and also, if desired, adjuvants, and, water to make up 100% by weight.
Patent AU-686290-B2 (AU)
Title: Method for separating an anhydrous fat into high and low melting point fractions, and device therefor
Inventor: PARMENTIER MICHEL
IPC: A23D9/00
Filed: 1994-12-09
Granted: 1998-02-05
Abstract: PCT No. PCT/FR94/01448 Sec. 371 Date Sep. 4, 1996 Sec. 102(e) Date Sep. 4, 1996 PCT Filed Dec. 9, 1994 PCT Pub. No. WO95/16012 PCT Pub. Date Jun. 15, 1995A method for separating an oil or anhydrous fat in hydrophobic liquid phase into a high melting point fraction and a low melting point fraction. The method comprises a step of tangential flow filtration of oil or the anhydrous fat in hydrophilic liquid phase on a hydrophobic membrane to cause separation of the oil or anhydrous fat into a retentate constituting a high melting point fraction and an ultrafiltrate constituting a low melting point fraction. The method is useful for producing butter with hard or soft texture characteristics.
Patent AU-759017-B2 (AU)
Title: Absorbent product comprising at least one thermoplastic component to bond layers
Inventor: MAGNUSSON BRITT ING
IPC: A61F13/15
Filed: 1999-10-01
Granted: 2003-04-03
Abstract: An absorbent product comprising a liquid-permeable casing layer (402), a liquid-barrier layer (413) and an absorption element (416) which is enclosed between the liquid-permeable casing layer (402) and the liquid-barrier layer (413), and a liquid-transfer layer (403) which is disposed between the liquid-permeable casing layer (402) and the absorption element (406). The envelope layer (402) is bonded in a pattern of distinct thermally produced bonds (405) to the liquid-transfer layer (403). The liquid-transfer layer (403) comprises 40-65% by weight network-creating function fibres which are substantially intact following the bonding-together of the envelope layer (402) and the liquid-transfer layer (403) and which have a fibre coarseness ranging from 6 denier to 12 denier and 35-60% by weight fibres comprising a weldable, thermoplastic component and having a fibre coarseness of at least 3 denier.
Patent AU-683151-B2 (AU)
Title: Novel N-pyridyl carboxamides and derivatives, processes for their preparation and the pharmaceutical compositions which contain them
Inventor: ROBERT JEAN-MICHEL
IPC: A61K31/4418
Filed: 1995-05-25
Granted: 1997-10-30
Abstract: N-Pyridyl carboxamides of formula (I), and their salts, enantiomers and diastereoisomers, are new. Q = 2- or 3- pyridyl (opt. as the N-oxide), substd. by R1-R4; R1, R2 = amino, alkylamino, dialkylamino, alkyl, OH, alkoxy, NO2, or halogen; R3, R4 = H or as R1; R = H or alkyl; A = alkylene or alkenylene (both opt. substd by alkyl) or a bond; Y = pyrazine, benzothiophene, 4-oxoÄ4HÜbenzopyran, pyrrole, pyrroline, pyrrolidine, piperidine, pyridine, or phthalimido, (all substd. by one or more R'), or chroman or benzopyran (both opt. substd. by one or more alkyl), 3-carboxy-5-alkyl-isoxazole or 3-alkoxycarbonyl-5-alkyl-isoxazole; and when A is not a bond, Y may also be thiophene (opt. substd. by one or more R'); R' = alkyl, alkoxy, CF3, OH, halogen, thiol or alkylthio; X = O, S, NH, or NR"; R" = alkyl, alkoxy, OH, NH2, arylalkyloxy, or aryloxy. Alkyl and alkoxy have 1-6C; aryl is phenyl or naphthyl; alkenylene has 2-6C.
Patent AU-659655-B2 (AU)
Title: Prerecorded record carrier SEALING CLERK DO NOT SEAL - SEALING FEE WILL BE REFUNDED
Inventor: LOKHOFF GERARDUS CORNELIS P
IPC: G11B5/86
Filed: 1992-07-29
Granted: 1995-05-25
Abstract: A prerecorded tape-like magnetic record carrier has on an A and a B side a number of adjacent tracks (Ta.1 to Ta.n, Tb.1 to Tb.n) running in longitudinal direction on the record carrier, the tracks on the A side, viewed in the play direction of the A side, comprising a lead in (LI), an information area (IA) in which the music programs are recorded on the A side, and a lead out (LO), the tracks on the B side, viewed in the play direction of the B side, comprising a lead in (LI), an information area (IB) in which the music programs are recorded on the B side, and a lead out (LO). The information areas on the A and B sides comprise frames (..., FRj-1, FRj, FRj+1, ...) of an essentially fixed length in which digital audio information representing the music programs are recorded. The lead ins on the A and B sides comprise frames with lead-in information, these frames having a length essentially equal to the length of the frames in the information areas. The lead outs on the A and B sides comprise frames with lead-out information, these frames having a length likewise essentially equal to the length of the frames in the information areas. The end of the information area in a track (Ta.i) on the A side, viewed in the play direction of the A side, is located past the beginning of the information area in a track (Tb.j) on the B side, in such a way that X lead-in frames, where for X it holds that 1 </= X </= 24, are located in the section of the lead in of said track (Tb.j) on the B side between the end of the information area in said track (Ta.j) on the A side and the beginning of the information area in the track on the B side. <IMAGE>
Patent AU-608046-B2 (AU)
Title: Incineration system for the destruction of hazardous wastes
Inventor: PHILLIPS PATRICK A
IPC: F23J15/04
Filed: 1988-07-08
Granted: 1991-03-21
Abstract: A process and apparatus for the controlled incineration of hazardous wastes comprising a two stage combustion of the waste into gases. The gases are thereafter cooled and cleaned by passing through primary and secondary scrubbers for cleaning. The invention also concerns an apparatus for the incineration of hazardous waste. The system cleans the gases produced by the incineration process so that hazardous materials are completely incinerated and converted into environmentally safe products at the site of their production.
Patent AU-608895-B2 (AU)
Title: Powdery medicine applicator device
Inventor: IKURA HIROSHI
IPC: A61M13/00
Filed: 1988-08-17
Granted: 1991-04-18
Abstract: A powdery medicine applicator device comprising a medicine-holding portion (1) having a powdery medicine (7) sealed therein, which has an opening formed at the head thereof to spray or inhale the powdery medicine (7), an air-introducing means (3, 10), and, if desired, a desiccantholding portion (9). The end of the applicator may be opened either by breaking off a knob (5) formed thereon or by perforation using a cap having a projection (6). The powdery medicine (7) is separated from the air-introducing means (3, 10) by an air-permeable partition wall (2).
Patent AU-625313-B2 (AU)
Title: Cell growth inhibitors and methods of treating cancer and cell proliferative diseases
Inventor: MARKAVERICH BARRY M
IPC: C07C43/164
Filed: 1988-07-20
Granted: 1992-07-09
Abstract: The present invention discloses new and useful compounds including methyl p-hydroxyphenyllactate, its analogues, chemical derivatives and chemically related compounds and their use as antitumor agents, as inhibitors of proliferative cell growth and as prophylactic agents to inhibit and prevent cancer and non-malignant cell growth.
Patent AU-613667-B2 (AU)
Title: Solution synthesis of an octapeptide
Inventor: CASTIGLIONE ROBERTO DE
IPC: C07K1/02
Filed: 1988-10-04
Granted: 1991-08-08
Abstract: An octapeptide, endowed with thymic humoral activity, of formula (A)  H-Leu-Glu-Asp-Gly-Pro-Lys-Phe-Leu-OH      (A) and pharmaceutically acceptable salts thereof are prepared by condensing a compound of the formula (B):    X-Leu-G @u-A@p-Gly-Pro-K      (B) wherein X is an amino protecting group, Y and Y min  are each optional and each independently represents a carboxy protecting group and K is a hydroxy or hydrazido group, with a compound of formula (C)    H-L @s-Phe-Leu-Q      (C) wherein W is an amino protecting group and Q represents a carboxy protecting group or a hydroxy group; deprotecting the resultant compound of the formula (D)    X-Leu-G @u-A@p-Gly-Pro-L @s-Phe-Leu-Q      (D) wherein X,Y,Y min ,W and Q are as defined above; and, if desired, converting the resulting peptide of formula (A) into a pharmaceutically acceptable salt thereof.
Patent AU-685273-B2 (AU)
Title: Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof
Inventor: RETTIG WOLFGANG J
IPC: C12N15/12
Filed: 1995-04-19
Granted: 1998-01-15
Abstract: The invention describes the identification and isolation of nucleic acid molecules which code for fibroblast activation protein alpha, or "FAP alpha ". Various applications of the isolated molecules are also described.
Patent AU-571865-B2 (AU)
Title: Melting scrap metal in magnetically stirred melt
Inventor: BAMJI PERVEZ JAL FRAMROZE
IPC: F27B3/04
Filed: 1984-03-27
Granted: 1988-04-28
Abstract: Solid scrap metal particles are ingested into molten metal by use of a linear induction motor which establishes a strong upstream in the molten metal adjacent one boundary wall to establish a standing wave at the surface and a corresponding downstream adjacent the opposite boundary, which is preferably in the form of a baffle having a metal outlet passage beneath it. The linear induction motor is conveniently positioned at a sidewell of a melting furnace and a continuous flow of molten metal through the sidewell is established in any convenient way.
Patent AU-658458-B2 (AU)
Title: Biphenylylquinuclidines, useful as squalene synthetase inhibitors
Inventor: BROWN GEORGE ROBERT
IPC: A61P9/10
Filed: 1992-10-27
Granted: 1995-04-13
Abstract: PCT No. PCT/GB92/01968 Sec. 371 Date Jun. 30, 1993 Sec. 102(e) Date Jun. 30, 1993 PCT Filed Oct. 27, 1992Biphenylylquinuclidine compounds of the formula I:    <IMAGE>  I  and pharmaceutically-acceptable salts thereof; wherein R1 is hydrogen or hydroxy; R2 is hydrogen; or R1 and R2 are joined together so that CR1-CR2 is a double bond; and one or both ring A and ring B may be optionally unsubstituted or independently substituted by one or more substituents selected from halogeno, hydroxy, amino, nitro, cyano, carboxy, carbamoyl, (1-6C)alkyl, (1-6C)alkoxy, (1-6C)alkylamino, di-[(1-6C)alkyl]amino, N-[(1-6C)alkyl]carbamoyl, N,N-di-[(1-6C)alkyl]carbamoyl, (1-6C)alkoxycarbonyl, (1-6C)alkylthio, (1-6C)alkylsulphinyl, (1-6C)alkylsulphonyl and halogeno-(1-6C)alkyl; are inhibitors of squalene synthase and are hence useful in treating diseases or medical conditions such as hypercholesterolemia, atherosclerosis and fungal diseases. Methods of using these compounds to treat such conditions, novel compounds, processes for making these compounds and pharmaceutical compositions containing them are claimed.
Patent AU-763406-B2 (AU)
Title: Hydrofining process using bulk group VIII/group VIB catalysts
Inventor: DEMMIN RICHARD A
IPC: B01J37/08
Filed: 2000-01-14
Granted: 2003-07-24
Abstract: Hydroprocessing of petroleum and chemical feedstocks using bulk Group VIII/Group VIB catalysts. Preferred catalysts include those comprised of Ni-Mo-W.
Patent AU-771162-B2 (AU)
Title: Pre-conditioning against cell death
Inventor: HAMET PAVEL
IPC: A61K35/14
Filed: 2000-01-11
Granted: 2004-03-18
Abstract: Apoptosis and/or necrosis related disorders in the mammalian body, namely radiation exposure disorders, chemical exposure and ingestion disorders, neurological disorders and physical trauma disorders, are treated, and their onset is counteracted by pre-conditioning, by extracting from the mammalian body an aliquot of blood, subjecting the extracted aliquot, ex vivo, to an oxidative stressor such as exposure to ozone gas, a temperature stressor, i.e. temperatures above or below body temperatures, and ultraviolet light, and re-injecting the treated blood aliquot into the mammalian body. The treatment has the effect of decreasing apoptosis/necrosis in the body, and of pre-conditioning the body better to withstand subsequently encountered apoptosis-inducing events.
Patent AU-693232-B2 (AU)
Title: Treatment of autoimmune diseases by oral administration of autoantigens
Inventor: WEINER HOWARD L
IPC: A61K38/095
Filed: 1995-09-01
Granted: 1998-06-25
Abstract: The invention is directed to a method of treating a T cell-mediated autoimmune disease in animals, including humans, by the oral administration of autoantigens, fragments of autoantigens, or analogs structurally related to those autoantigens, which are specific for the particular autoimmune disease. The method of the invention includes both prophylactic and therapeutic measures.
Patent AU-751224-B2 (AU)
Title: Environmentally friendly aqueous architectural coating compositions
Inventor: HORLEY SUSAN MARY
IPC: C08F251/00
Filed: 1999-03-31
Granted: 2002-08-08
Abstract: An environmentally friendly stable aqueous optionally structured water-resistant architectural coating composition (especially a paint) containing a film-forming binder polymer composed of a starch modified by the presence of carboxylic acid or inorganic carboxylate groups and bonded (probably grafted) to chains of copolymerised mono-ethylenically unsaturated monomers (e.g. "acrylic", "vinyl" or "styrenic" copolymers) permitting a stable aqueous dispersion of the binder polymer to be made which retains good water-resistance in the dried paint. The modified starch allows paints to be made with less dependence on materials obtained from non-renewable resources whilst retaining a low water-sensitivity.